Q-TWiST analysis of survival benefits with brigatinib versus crizotinib in patients with anaplastic lymphoma kinase-positive non-small cell lung cancer based on results of the ALTA-1L trial
Garcia Campelo, M.R., Wan, Y., Lin, H.M., Chen, T., Shen, J., Zhang, P., Camidge, D.R.
Published in Lung cancer (Amsterdam, Netherlands) (01.11.2023)
Published in Lung cancer (Amsterdam, Netherlands) (01.11.2023)
Get full text
Journal Article
Efficacy of tyrosine kinase inhibitors in EGFR-mutant lung cancer women in a real-world setting: the WORLD07 database
Remon, J., Isla, D., Garrido, P., de Castro, J., Majem, M., Viñolas, N., Artal, A., Carcereny, E., García-Campelo, M. R., Lianes, P., Provencio, M., Juan, O., Diz, P., Blanco, R., Lopez-Castro, R., Maestu, I., Vadell, C., Felip, E.
Published in Clinical & translational oncology (01.12.2017)
Published in Clinical & translational oncology (01.12.2017)
Get full text
Journal Article
Brigatinib (BRG) vs crizotinib (CRZ) in the phase III ALTA-1L trial
Califano, R., Hochmair, M.J., Gridelli, C., Delmonte, A., Garcia Campelo, M.R., Bearz, A., Griesinger, F., Morabito, A., Felip, E., Ghosh, S., Tiseo, M., Haney, J., Kerstein, D., Popat, S., Camidge, D.R.
Published in Annals of oncology (01.04.2019)
Published in Annals of oncology (01.04.2019)
Get full text
Journal Article
Effect of central nervous system (CNS) metastases in a real-world multicenter cohort study of Spanish ALK-positive non-small cell lung cancer (NSCLC) patients (p)
Angelats, L., Garcia Campelo, M.R., Bernabe Caro, R., Arriola Aperribay, E., Calvo de Juan, V., Barba Joaquín, A., Vinolas Segarra, N., Gil Moreno, M.D.L.L., Vilà Martinez, L., Juan Vidal, O.J., Vilariño Quintela, N., Cobo, M., Sais, E., Domine Gomez, M., Fernandez Nuñez, N., Coves Sarto, J., Marse Fabregat, R., Esteve Gomez, A.M., Rodríguez-Abreu, D., Carcereny Costa, E.
Published in Annals of oncology (01.04.2019)
Published in Annals of oncology (01.04.2019)
Get full text
Journal Article
The Role of the Liquid Biopsy in Decision-Making for Patients with Non-Small Cell Lung Cancer
Akhoundova, D., Mosquera Martinez, J., Musmann, L. E., Britschgi, C., Rütsche, C., Rechsteiner, M., Nadal, E., Garcia Campelo, M. R., Curioni-Fontecedro, A.
Published in Journal of clinical medicine (16.11.2020)
Published in Journal of clinical medicine (16.11.2020)
Get full text
Journal Article
LungBEAM: A prospective multicenter trial to monitor EGFR mutations using BEAMing technology in stage IV NSCLC patients
Garrido Lopez, P., Felip, E., Paz-Ares, L., Majem, M., Moran, T., Gonzalez-Larriba, J.L., Bosch Barrera, J., Trigo Perez, J.M., Garcia Campelo, M.R., Sanchez Torres, J.M., Isla, D., Vinolas Segarra, N., Camps, C., Insa Molla, A., Juan Vidal, O.J., Massutí, B., Paredes Lario, A., Artal-Cortes, A., Lopez-Brea Piqueras, M., Palacios Calvo, J.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Intracranial efficacy of brigatinib (BRG) vs crizotinib (CRZ) in the phase III ALTA-1L trial
Popat, S., Kim, H.R., Ahn, M.-J., Yang, J.C.-H., Han, J.-Y., Hochmair, M.J., Lee, K.H., Delmonte, A., Garcia Campelo, M.R., Kim, D.-W., Griesinger, F., Felip, E., Califano, R., Spira, A.I., Gettinger, S., Tiseo, M., Haney, J., Kerstein, D., Camidge, D.R.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Randomized open-label controlled study of cancer vaccine OSE2101 versus chemotherapy in HLA-A2-positive patients with advanced non-small-cell lung cancer with resistance to immunotherapy: ATALANTE-1
Besse, B., Felip, E., Garcia Campelo, R., Cobo, M., Mascaux, C., Madroszyk, A., Cappuzzo, F., Hilgers, W., Romano, G., Denis, F., Viteri, S., Debieuvre, D., Galetta, D., Baldini, E., Razaq, M., Robinet, G., Maio, M., Delmonte, A., Roch, B., Masson, P., Schuette, W., Zer, A., Remon, J., Costantini, D., Vasseur, B., Dziadziuszko, R., Giaccone, G., Zemanová, M., Besse, B., Bonnet, C., Cadranel, J., Chouaid, C., Cortot, A., Debieuvre, D., Delclaux, B., Denis, F., Duchemann, B., El Kouri, C., Ferrand, F.R., Ginoux, M., Hilgers, W., Madroszyk, A., Masson, P., Mazieres, J., Molinier, O., Moro-Sibilot, D., Pichon, E., Mascaux, C., Robinet, G., Roch, B., Zalcman, G., Schmidtke-Schrezenmeier, G., Schuette, W., Urban, L., Gottfried, M., Nechushtan, H., Peled, N., Wollner, M., Zer, A., Baldini, E., Bonanno, L., Bonetti, A., Cappuzzo, F., Delmonte, A., Galetta, D., Maio, M., Minotti, V., Rea, A., Romano, G., Tassinari, D., Tonini, G., Dziadziuszko, R., Karaszewska, B., Szczęsna, A., Cobo, M., De Castro, J., Felip, E., Garcia Campelo, M.R., Hernández, A., Moran, T., Provencio, M., Viteri, S., Dasgupta, A., Gabrail, N., Giaccone, G., Harshad, A., Liu, S., Oubre, D., Panikkar, R., Razaq, M., Sanborn, R.
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article
106OBrigatinib (BRG) vs crizotinib (CRZ) in the phase III ALTA-1L trial
Califano, R, Hochmair, M J, Gridelli, C, Delmonte, A, Garcia Campelo, M R, Bearz, A, Griesinger, F, Morabito, A, Felip, E, Ghosh, S, Tiseo, M, Haney, J, Kerstein, D, Popat, S, Camidge, D R
Published in Annals of oncology (01.04.2019)
Published in Annals of oncology (01.04.2019)
Get full text
Journal Article
141PEffect of central nervous system (CNS) metastases in a real-world multicenter cohort study of Spanish ALK-positive non-small cell lung cancer (NSCLC) patients (p)
Angelats, L, Garcia Campelo, M R, Bernabe Caro, R, Arriola Aperribay, E, Calvo de Juan, V, Barba Joaquín, A, Vinolas Segarra, N, Gil Moreno, M D L L, Vilà Martinez, L, Juan Vidal, O J, Vilariño Quintela, N, Cobo, M, Sais, E, Domine Gomez, M, Fernandez Nuñez, N, Coves Sarto, J, Marse Fabregat, R, Esteve Gomez, A M, Rodríguez-Abreu, D, Carcereny Costa, E
Published in Annals of oncology (01.04.2019)
Published in Annals of oncology (01.04.2019)
Get full text
Journal Article
LBA58Intracranial efficacy of brigatinib (BRG) vs crizotinib (CRZ) in the phase III ALTA-1L trial
Popat, S, Kim, H R, Ahn, M-J, Yang, J C-H, Han, J-Y, Hochmair, M J, Lee, K H, Delmonte, A, Garcia Campelo, M R, Kim, D-W, Griesinger, F, Felip, E, Califano, R, Spira, A I, Gettinger, S, Tiseo, M, Haney, J, Kerstein, D, Camidge, D R
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
121PLungBEAM: A prospective multicenter trial to monitor EGFR mutations using BEAMing technology in stage IV NSCLC patients
Garrido Lopez, P, Felip, E, Paz-Ares, L, Majem, M, Moran, T, Gonzalez-Larriba, J L, Bosch Barrera, J, Trigo Perez, J M, Garcia Campelo, M R, Sanchez Torres, J M, Isla, D, Vinolas Segarra, N, Camps, C, Insa Molla, A, Juan Vidal, O J, Massutí, B, Paredes Lario, A, Artal-Cortes, A, Lopez-Brea Piqueras, M, Palacios Calvo, J
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Astrocyte elevated gene 1 (AEG-1) mRNA expression in non-small cell lung cancer (NSCLC) patients (p) with epidermal growth factor receptor (EGFR) mutations
Viteri, S., Rosell, R., Costa, C., Taron, M., Sanchez, J. J., Benlloch, S., Moran, T., Massuti, B., Camps, C., Majem, M., Carcereny, E., Cardenal, F., Gasco, A., Mederos, N., Magri, I., Rolfo, C. D., Garcia-Campelo, M. R., Gimenez Capitan, A., de Aguirre, I., Queralt, C.
Published in Journal of clinical oncology (20.05.2011)
Published in Journal of clinical oncology (20.05.2011)
Get full text
Journal Article
Initial detection of the double epidermal growth factor receptor (EGFR) mutation (L858R or deletion in exon 19 [del 19] plus T790M) in non-small cell lung cancer (NSCLC) patients (p) with brain metastases (mets) and the influence of first-line chemotherapy on outcome to erlotinib
Moran, T., Sanchez, J. J., Molina, M. A., Bertran-Alamillo, J., Gimenez Capitan, A., Benlloch, S., Taron, M., Massuti, B., Camps, C., Porta, R., Isla, D., Lopez-Vivanco, G., Bover, I., Garcia-Campelo, M. R., Rolfo, C. D., Salazar, F., Carcereny, E., Cardenal, F., Magri, I., Rosell, R.
Published in Journal of clinical oncology (20.05.2011)
Published in Journal of clinical oncology (20.05.2011)
Get full text
Journal Article
Impact of corticosteroids and antibiotics on efficacy of immune-checkpoint inhibitors in advanced non-small cell lung cancer
Martinez, J Mosquera, Riuvadets, M., García- Campelo, M.-R., Lopez, J Serra, Palacios, G Anguera, Melo, P Gallardo, Sullivan, I., Joaquin, A Barba, Tarruella, M Majem, Rendo, C Reboredo, González, P Cordeiro
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
1292PImpact of corticosteroids and antibiotics on efficacy of immune-checkpoint inhibitors in advanced non-small cell lung cancer
Martinez, J Mosquera, Riuvadets, M, García- Campelo, M-R, Lopez, J Serra, Palacios, G Anguera, Melo, P Gallardo, Sullivan, I, Joaquin, A Barba, Tarruella, M Majem, Rendo, C Reboredo, González, P Cordeiro
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
1292P - Impact of corticosteroids and antibiotics on efficacy of immune-checkpoint inhibitors in advanced non-small cell lung cancer
Martinez, J Mosquera, Riuvadets, M., García- Campelo, M.-R., Lopez, J Serra, Palacios, G Anguera, Melo, P Gallardo, Sullivan, I., Joaquin, A Barba, Tarruella, M Majem, Rendo, C Reboredo, González, P Cordeiro
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
ATALANTE-1 randomized phase III trial, OSE-2101 versus standard treatment as second or third-line in HLA-A2 positive advanced non-small cell lung cancer (NSCLC) patients
Felip, E., Besse, B., Dziadziuszko, R., Cobo Dols, M., Denis, F., García-Campelo, M.-R., Debieuvre, D., Catino, A., Moran Bueno, M.T., Madroszyk Flandin, A.-C., Masson, P., Chouaid, C., Lianes, P., Cappuzzo, F., Delmonte, A., Robinet, G., Romano, G., Gabarre, V., Remon Masip, J., Giaccone, G.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
1592TiP - ATALANTE-1 randomized phase III trial, OSE-2101 versus standard treatment as second or third-line in HLA-A2 positive advanced non-small cell lung cancer (NSCLC) patients
Felip, E., Besse, B., Dziadziuszko, R., Cobo Dols, M., Denis, F., García-Campelo, M.-R., Debieuvre, D., Catino, A., Moran Bueno, M.T., Madroszyk Flandin, A.-C., Masson, P., Chouaid, C., Lianes, P., Cappuzzo, F., Delmonte, A., Robinet, G., Romano, G., Gabarre, V., Remon Masip, J., Giaccone, G.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
Immune cell biomarkers on neo-adjuvant chemo-immunotherapy treatment for resectable stage IIIA NSCLC patients
Laza-Briviesca, R., Cruz-Bermudez, A., Casarrubios, M., Nadal, E., Molla, M A Insa, García-Campelo, M.-R., Huidobro, G., Gomez, M Domine, Tarruella, M Majem, Abreu, D Rodriguez, Martinez-Marti, A., De Carpeno, JCastro, Dols, M Cobo, Vivanco, G López, del Barco Morillo, E., Bernabé, R., Viñolas, N., Aranda, I C Barneto, Sureda, B Massuti, Provencio, M.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article